Pure Global AI
NCT06118229Recruiting

A Study to Explore the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients

A Prospective Observational Study to the Role and Impact of Wearable Smart Devices in Perioperative NSCLC Patients
The First Affiliated Hospital of Guangzhou Medical UniversityClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Non Small Cell Lung Cancer
Drug/Device/Intervention
Wearable smart devices and PROs
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
The First Affiliated Hospital of Guangzhou Medical University
Location
Guangzhou, China
Timeline & enrollment
Phase
N/A
Start date
Mar 09, 2023
End date
Jun 30, 2024
Enrollment
300 participants
Primary outcome

Postoperative length of hospital stay

Summary

The trial was designed as a single-center non-interventional prospective observational study
 to explore the role and impact of wearable smart devices in perioperative NSCLC patients.

ICD-10 classifications
Secondary malignant neoplasm of lungMalignant neoplasm: Lower lobe, bronchus or lungMalignant neoplasm: Middle lobe, bronchus or lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm of bronchus and lung
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06118229
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06118229 through Pure Global AI's free database. This phase not specified trial is sponsored by The First Affiliated Hospital of Guangzhou Medical University and is currently Recruiting. The study focuses on Non Small Cell Lung Cancer. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.